NVDA vs SBUX: Which Is the Better Buy?

Side-by-side comparison of NVIDIA Corporation and Starbucks Corporation โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
NVIDIA Corporation ยท Technology
$225.07
+45.0% upside to fair value
Med Conviction Grade B High Quality
VS
Starbucks Corporation ยท Consumer Cyclical
$96.67
+12.3% upside to fair value
Med Conviction Grade C
QuantHub Verdict
NVDA has more upside to fair value (+45.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric NVDA SBUX
Current Price $225.07 $96.67
Fair Value Estimate $326.35 $108.52
Upside to Fair Value +45.0% +12.3%
Market Cap $5,451.4B $110.2B
Forward P/E โ€” โ€”
EV / EBITDA 23.4x 22.0x
Price / Sales 18.0x 2.9x
Price / FCF 42.9x 30.4x
Revenue Growth YoY +105.9% -1.4%
Gross Margin 74.7% 31.7%
Operating Margin 65.2% 9.4%
Return on Equity 110.1% -24.3%
Dividend Yield 0.23% 2.57%
FCF Yield 2.33% 3.29%
Analyst Consensus Strong Buy Buy
Investment Thesis
NVDA โ€” NVIDIA Corporation
NVIDIA designs the accelerated computing platforms at the center of the AI buildout, spanning data center GPUs, Mellanox networking, AI enterprise software, gaming GeForce GPUs, professional visualization, and automotive platforms, with 42,000 employees and a $5.45 trillion market capitalization. Business quality is exceptional on the fundamentals: TTM gross margin of 74.7%, TTM operating margin โ€ฆ
SBUX โ€” Starbucks Corporation
Starbucks is the world's largest specialty coffee retailer, operating company-owned and licensed coffeehouses across North America, International, and Channel Development segments, with a brand that has historically supported premium pricing and global scale. The business quality is currently strained: revenue declined 1.4% year over year in the most recent quarter, TTM operating margin is 9.4%, โ€ฆ
Accumulation Zones
Metric NVDA SBUX
Zone Low $244.76 $81.39
Zone High $277.40 $92.24
In Buy Zone? Yes No
โ† NVDA Research    SBUX Research โ†’    All Research